1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Pathology Analysis & Statistics 2021 - Europe

Pathology Analysis & Statistics 2021 - Europe

Customer Support

Talk to Ahmad

+1 718 618 4302

Publishers

  • All
    • Global Markets Direct

All regions

1-17 of 17 reports

Rubella (German Measles) (Infectious Disease) - Drugs in Development, 2021

  • $ 2000
  • October 2021
  • 44 pages

Rubella (German Measles) (Infectious Disease) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Rubella (German Measles) - Drugs In Development, 2021, ...

  • Germany
  • Infectious Disease
  • Drug Development
  • Industry analysis
  • Health Provider Density
  • Infectious Disease Prevalence

Post Menopausal Osteoporosis (Musculoskeletal) - Drugs In Development, 2021

  • $ 2000
  • August 2021
  • 137 pages

Post Menopausal Osteoporosis (Musculoskeletal) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Post Menopausal Osteoporosis - Drugs In Development, ...

  • World
  • Shandong
  • Musculoskeletal Disorder
  • Drug Development
  • Industry analysis
  • Pharmaceutical Registrations
  • Number Of R&D Personnel

Pompe Disease (Musculoskeletal) - Drugs In Development, 2021

  • $ 2000
  • August 2021
  • 121 pages

Pompe Disease (Musculoskeletal) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Pompe Disease - Drugs In Development, 2021, provides an overview of ...

  • World
  • Belgium
  • Neurological Disorder
  • Drug Development
  • Industry analysis
  • Number Of R&D Personnel
  • Manufacturing Output

Thalassemia (Hematology) - Drugs In Development, 2021

  • $ 2000
  • July 2021
  • 278 pages

Thalassemia (Hematology) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Thalassemia - Drugs In Development, 2021, provides an overview of the Thalassemia ...

  • World
  • Spain
  • Blood Disease
  • Drug Development
  • Industry analysis
  • Stem Cell Transplantation
  • Pharmaceutical Registrations

Idiopathic Thrombocytopenic Purpura (Hematology) - Drugs In Development, 2021

  • $ 2000
  • July 2021
  • 205 pages

Idiopathic Thrombocytopenic Purpura (Hematology) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Idiopathic Thrombocytopenic Purpura - Drugs In Development, ...

  • World
  • South Africa
  • Blood Disease
  • Autoimmune Disease
  • Industry analysis
  • Pharmaceutical Registrations
  • Drug Approval

Influenza A Virus, H3N2 Subtype Infections (Infectious Disease) - Drugs In Development, 2021

  • $ 2000
  • July 2021
  • 173 pages

Influenza A Virus, H3N2 Subtype Infections (Infectious Disease) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Influenza A Virus, H3N2 Subtype Infections ...

  • World
  • Netherlands
  • Influenza
  • Drug Development
  • Industry analysis
  • Vaccination Coverage
  • Drug Approval

B-Cell Chronic Lymphocytic Leukemia (Oncology) - Drugs In Development, 2021

  • $ 2000
  • July 2021
  • 220 pages

B-Cell Chronic Lymphocytic Leukemia (Oncology) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide B-Cell Chronic Lymphocytic Leukemia - Drugs In Development, ...

  • World
  • Northern Europe
  • Leukemia
  • Drug Development
  • Industry analysis
  • Cause-Specific Mortality Rate
  • Stem Cell Transplantation

Ebolavirus Infections (Ebola Hemorrhagic Fever) (Infectious Disease) - Drugs In Development, 2021

  • $ 2000
  • July 2021
  • 332 pages

Ebolavirus Infections (Ebola Hemorrhagic Fever) (Infectious Disease) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Ebolavirus Infections (Ebola ...

  • World
  • United States
  • Infectious Disease
  • Drug Development
  • Industry analysis
  • Mortality Rate
  • Hospital Discharge

Epstein-Barr Virus (HHV-4) Infections (Infectious Disease) - Drugs In Development, 2021

  • $ 2000
  • July 2021
  • 262 pages

Epstein-Barr Virus (HHV-4) Infections (Infectious Disease) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Epstein-Barr Virus (HHV-4) Infections - ...

  • World
  • China
  • Infectious Disease
  • Drug Development
  • Industry analysis
  • Stem Cell Transplantation
  • Pharmaceutical Registrations

Influenza A Virus, H5N1 Subtype Infections (Infectious Disease) - Drugs In Development, 2021

  • $ 2000
  • July 2021
  • 178 pages

Influenza A Virus, H5N1 Subtype Infections (Infectious Disease) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Influenza A Virus, H5N1 Subtype Infections ...

  • World
  • Netherlands
  • Influenza
  • Drug Development
  • Industry analysis
  • Vaccination Coverage
  • Drug Approval

Influenza A Virus, H1N1 Subtype Infections (Infectious Disease) - Drugs In Development, 2021

  • $ 2000
  • July 2021
  • 291 pages

Influenza A Virus, H1N1 Subtype Infections (Infectious Disease) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Influenza A Virus, H1N1 Subtype Infections ...

  • World
  • United States
  • Influenza
  • Drug Development
  • Industry analysis
  • Vaccination Coverage
  • Drug Approval

Glomerulonephritis (Genitourinary Disorders) - Drugs In Development, 2021

  • $ 2000
  • July 2021
  • 403 pages

Glomerulonephritis (Genitourinary Disorders) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Glomerulonephritis - Drugs In Development, 2021, provides ...

  • Spain
  • Jiangsu
  • Drug Development
  • Autoimmune Disease
  • Industry analysis
  • Pharmaceutical Registrations
  • Drug Approval

Allergic Rhinitis (Respiratory) - Drugs In Development, 2021

  • $ 2000
  • July 2021
  • 218 pages

Allergic Rhinitis (Respiratory) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Allergic Rhinitis - Drugs In Development, 2021, provides an overview ...

  • World
  • China
  • Respiratory Disease
  • Allergy Drug
  • Industry analysis
  • Pharmaceutical Registrations
  • Medicine Use

Cystic Fibrosis (Respiratory) - Drugs In Development, 2021

  • $ 2500
  • July 2021
  • 545 pages

Cystic Fibrosis (Respiratory) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Cystic Fibrosis - Drugs In Development, 2021, provides an overview of ...

  • World
  • Europe
  • Cystic Fibrosis
  • Industry analysis

Epidermolysis Bullosa (Dermatology) - Drugs In Development, 2021

  • $ 2000
  • July 2021
  • 169 pages

Epidermolysis Bullosa (Dermatology) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Epidermolysis Bullosa - Drugs In Development, 2021, provides an ...

  • World
  • Spain
  • Dermatological Condition
  • Drug Development
  • Industry analysis
  • Pharmaceutical Registrations
  • Dropout Rate

Peanut Allergy (Immunology) - Drugs In Development, 2021

  • $ 2000
  • July 2021
  • 176 pages

Peanut Allergy (Immunology) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Peanut Allergy - Drugs In Development, 2021, provides an overview of the ...

  • World
  • United Kingdom
  • Allergy
  • Drug Development
  • Industry analysis
  • Pharmaceutical Registrations
  • Dropout Rate

Myocarditis (Cardiovascular) - Drugs In Development, 2021

  • $ 2000
  • June 2021
  • 57 pages

Myocarditis (Cardiovascular) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Myocarditis (Cardiovascular) - Drugs In Development, 2021, provides an ...

  • World
  • Sweden
  • Cardiovascular Disease
  • Drug Development
  • Industry analysis
  • Child Mortality
  • Hospital Discharge



Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on